Tempus Pro Monitor Registry
A Post Market Clinical Follow-up Study to Evaluate the Safety and Clinical Performance of the Tempus Pro, a Multi-parameter Vital Signs Monitoring Device With Specific Reference to ECG Recordings and Data Transmission Using Telemedicine
Sponsor: North American Science Associates, LLC
This observational or N/A phase trial investigates Emergency Care and Sudden Cardiac Arrest and is currently completed. North American Science Associates, LLC leads this study, which shows 15 recorded versions since 2024 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
15 versions recorded-
Apr 2025 — Present [monthly]
Completed
-
Oct 2024 — Apr 2025 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation
-
Jun 2024 — Jul 2024 [monthly]
Enrolling By Invitation
Status: Not Yet Recruiting → Enrolling By Invitation
▶ Show 10 earlier versions
-
Apr 2024 — Jun 2024 [monthly]
Not Yet Recruiting
-
Feb 2024 — Apr 2024 [monthly]
Not Yet Recruiting
-
Nov 2023 — Feb 2024 [monthly]
Not Yet Recruiting
-
Sep 2023 — Nov 2023 [monthly]
Not Yet Recruiting
-
Jun 2023 — Sep 2023 [monthly]
Not Yet Recruiting
-
Apr 2023 — Jun 2023 [monthly]
Not Yet Recruiting
-
Feb 2023 — Apr 2023 [monthly]
Not Yet Recruiting
-
Jan 2023 — Feb 2023 [monthly]
Not Yet Recruiting
-
Dec 2022 — Jan 2023 [monthly]
Not Yet Recruiting
-
Nov 2022 — Dec 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- North American Science Associates, LLC
- Philips Clinical & Medical Affairs Global
For direct contact, visit the study record on ClinicalTrials.gov .